載入...
Downregulation of ER-α36 expression sensitizes HER2 overexpressing breast cancer cells to tamoxifen
Tamoxifen provided a successful treatment for ER-positive breast cancer for many years. However, HER2 overexpressing breast cancer cells respond poorly to tamoxifen therapy presumably by pass. The molecular mechanisms underlying development of tamoxifen resistance have not been well established. Rec...
Na minha lista:
| 發表在: | Am J Cancer Res |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
e-Century Publishing Corporation
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4396031/ https://ncbi.nlm.nih.gov/pubmed/25973295 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|